 Mark Erickson
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 42 | 2024 | 179 | 7.570 |
Why?
| | Spinal Fusion | 38 | 2024 | 200 | 7.560 |
Why?
| | Surgical Wound Infection | 9 | 2022 | 248 | 1.840 |
Why?
| | Thoracic Vertebrae | 14 | 2024 | 68 | 1.780 |
Why?
| | Internal Fixators | 5 | 2015 | 36 | 1.430 |
Why?
| | Kyphosis | 8 | 2024 | 33 | 1.360 |
Why?
| | Bone Screws | 8 | 2024 | 114 | 1.330 |
Why?
| | Spine | 11 | 2022 | 136 | 1.310 |
Why?
| | Lumbar Vertebrae | 6 | 2015 | 209 | 1.200 |
Why?
| | Pain, Postoperative | 4 | 2017 | 191 | 1.040 |
Why?
| | Radiography | 13 | 2020 | 812 | 1.040 |
Why?
| | Musculoskeletal Diseases | 2 | 2019 | 54 | 0.770 |
Why?
| | Fitness Trackers | 1 | 2019 | 8 | 0.670 |
Why?
| | Postoperative Complications | 9 | 2023 | 2128 | 0.660 |
Why?
| | Musculoskeletal System | 1 | 2019 | 43 | 0.640 |
Why?
| | Patient Care Team | 3 | 2012 | 517 | 0.610 |
Why?
| | Child | 36 | 2023 | 18412 | 0.590 |
Why?
| | Follow-Up Studies | 11 | 2022 | 4411 | 0.580 |
Why?
| | Vancomycin | 1 | 2018 | 75 | 0.580 |
Why?
| | Orthopedics | 1 | 2019 | 121 | 0.570 |
Why?
| | Treatment Outcome | 24 | 2024 | 9088 | 0.560 |
Why?
| | Adolescent | 32 | 2024 | 17841 | 0.550 |
Why?
| | Retrospective Studies | 28 | 2024 | 12546 | 0.540 |
Why?
| | Spinal Diseases | 2 | 2017 | 39 | 0.530 |
Why?
| | Reoperation | 2 | 2016 | 514 | 0.520 |
Why?
| | Propionibacterium acnes | 1 | 2015 | 8 | 0.490 |
Why?
| | Intervertebral Disc | 1 | 2015 | 35 | 0.490 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 44 | 0.470 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 340 | 0.460 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 70 | 0.460 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2015 | 61 | 0.460 |
Why?
| | Neuromuscular Diseases | 2 | 2016 | 89 | 0.440 |
Why?
| | Sutures | 1 | 2013 | 50 | 0.440 |
Why?
| | Home Nursing | 1 | 2013 | 26 | 0.430 |
Why?
| | Humans | 62 | 2024 | 114662 | 0.420 |
Why?
| | Suture Techniques | 1 | 2013 | 115 | 0.420 |
Why?
| | Casts, Surgical | 1 | 2012 | 28 | 0.410 |
Why?
| | Soft Tissue Injuries | 1 | 2013 | 31 | 0.410 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.410 |
Why?
| | Bupivacaine | 1 | 2012 | 31 | 0.410 |
Why?
| | Equipment Failure | 1 | 2013 | 106 | 0.400 |
Why?
| | Metals | 1 | 2013 | 106 | 0.400 |
Why?
| | Amides | 1 | 2012 | 86 | 0.390 |
Why?
| | Humeral Fractures | 1 | 2012 | 46 | 0.390 |
Why?
| | Fracture Fixation | 1 | 2012 | 75 | 0.390 |
Why?
| | Preoperative Care | 2 | 2011 | 319 | 0.390 |
Why?
| | Patient Satisfaction | 2 | 2013 | 578 | 0.380 |
Why?
| | Male | 35 | 2022 | 55583 | 0.370 |
Why?
| | Orthopedic Procedures | 2 | 2018 | 208 | 0.360 |
Why?
| | Female | 36 | 2022 | 59493 | 0.340 |
Why?
| | Bone Nails | 2 | 2012 | 58 | 0.330 |
Why?
| | Blood Loss, Surgical | 2 | 2021 | 84 | 0.320 |
Why?
| | Anti-Bacterial Agents | 4 | 2018 | 1481 | 0.300 |
Why?
| | Caregivers | 2 | 2022 | 717 | 0.300 |
Why?
| | Diskectomy | 1 | 2007 | 15 | 0.290 |
Why?
| | Decompression, Surgical | 2 | 2007 | 93 | 0.280 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2007 | 48 | 0.280 |
Why?
| | Cervical Vertebrae | 1 | 2007 | 100 | 0.270 |
Why?
| | Prospective Studies | 13 | 2023 | 6219 | 0.250 |
Why?
| | Hospitals, Pediatric | 5 | 2017 | 480 | 0.240 |
Why?
| | Risk Factors | 8 | 2018 | 8632 | 0.220 |
Why?
| | Practice Guidelines as Topic | 4 | 2017 | 1394 | 0.220 |
Why?
| | Algorithms | 1 | 2010 | 1468 | 0.210 |
Why?
| | Cohort Studies | 5 | 2023 | 4895 | 0.210 |
Why?
| | Muscle Relaxants, Central | 1 | 2022 | 9 | 0.200 |
Why?
| | Osteotomy | 4 | 2023 | 146 | 0.200 |
Why?
| | Pelvic Bones | 1 | 2004 | 126 | 0.190 |
Why?
| | Neural Tube Defects | 1 | 2022 | 61 | 0.190 |
Why?
| | Laminectomy | 1 | 2021 | 24 | 0.190 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 10 | 0.190 |
Why?
| | Length of Stay | 4 | 2017 | 962 | 0.190 |
Why?
| | Postoperative Care | 2 | 2015 | 222 | 0.190 |
Why?
| | Pain Measurement | 3 | 2017 | 444 | 0.180 |
Why?
| | Thoracoplasty | 1 | 2020 | 2 | 0.180 |
Why?
| | Parents | 2 | 2020 | 1186 | 0.170 |
Why?
| | Analgesics, Opioid | 2 | 2017 | 771 | 0.170 |
Why?
| | Scheuermann Disease | 1 | 2019 | 1 | 0.170 |
Why?
| | Pain | 2 | 2022 | 705 | 0.160 |
Why?
| | Quality of Life | 4 | 2023 | 2353 | 0.160 |
Why?
| | Bone Wires | 2 | 2011 | 23 | 0.150 |
Why?
| | Administration, Topical | 1 | 2018 | 138 | 0.150 |
Why?
| | Patient Preference | 1 | 2020 | 167 | 0.150 |
Why?
| | Incidence | 3 | 2019 | 2313 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2019 | 147 | 0.150 |
Why?
| | Surgeons | 1 | 2021 | 239 | 0.140 |
Why?
| | Osteogenesis Imperfecta | 1 | 2017 | 13 | 0.140 |
Why?
| | Drug Utilization Review | 1 | 2017 | 57 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 96 | 0.140 |
Why?
| | Child, Preschool | 5 | 2017 | 9114 | 0.140 |
Why?
| | Patient Participation | 1 | 2020 | 359 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2018 | 233 | 0.140 |
Why?
| | Morphine | 1 | 2017 | 121 | 0.130 |
Why?
| | Comorbidity | 2 | 2011 | 1448 | 0.130 |
Why?
| | Age of Onset | 2 | 2018 | 446 | 0.130 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1214 | 0.120 |
Why?
| | Debridement | 1 | 2015 | 73 | 0.120 |
Why?
| | Fluoroscopy | 1 | 2015 | 139 | 0.120 |
Why?
| | Informed Consent | 1 | 2016 | 161 | 0.120 |
Why?
| | Patient Readmission | 2 | 2017 | 610 | 0.120 |
Why?
| | Cost Savings | 1 | 2015 | 74 | 0.120 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 811 | 0.120 |
Why?
| | Blood Transfusion | 1 | 2017 | 293 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 493 | 0.120 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 132 | 0.120 |
Why?
| | Pain Management | 1 | 2017 | 288 | 0.120 |
Why?
| | Patient Compliance | 1 | 2018 | 525 | 0.110 |
Why?
| | Device Removal | 1 | 2015 | 126 | 0.110 |
Why?
| | Hospital Charges | 1 | 2013 | 39 | 0.110 |
Why?
| | United States | 6 | 2020 | 12181 | 0.110 |
Why?
| | Quality Improvement | 3 | 2018 | 950 | 0.110 |
Why?
| | Guideline Adherence | 1 | 2017 | 490 | 0.110 |
Why?
| | Asepsis | 1 | 2013 | 1 | 0.110 |
Why?
| | Syringomyelia | 2 | 2003 | 11 | 0.110 |
Why?
| | Drug Administration Schedule | 2 | 2012 | 718 | 0.110 |
Why?
| | Osteolysis | 1 | 2013 | 14 | 0.100 |
Why?
| | Off-Label Use | 1 | 2013 | 51 | 0.100 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 43 | 0.100 |
Why?
| | Risk Assessment | 2 | 2012 | 2968 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2012 | 81 | 0.100 |
Why?
| | Single-Blind Method | 1 | 2012 | 258 | 0.100 |
Why?
| | Reproducibility of Results | 4 | 2021 | 2763 | 0.090 |
Why?
| | Elective Surgical Procedures | 1 | 2012 | 151 | 0.090 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 4622 | 0.090 |
Why?
| | Intraoperative Period | 1 | 2011 | 51 | 0.090 |
Why?
| | Injury Severity Score | 1 | 2012 | 499 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2012 | 1226 | 0.080 |
Why?
| | Dibenzothiazepines | 1 | 2009 | 17 | 0.080 |
Why?
| | Interprofessional Relations | 1 | 2011 | 249 | 0.080 |
Why?
| | Nerve Growth Factor | 1 | 2009 | 27 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 65 | 0.080 |
Why?
| | Edema | 1 | 2009 | 119 | 0.080 |
Why?
| | Qualitative Research | 1 | 2013 | 934 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1842 | 0.080 |
Why?
| | Delphi Technique | 2 | 2022 | 160 | 0.070 |
Why?
| | Spinal Stenosis | 1 | 2007 | 24 | 0.070 |
Why?
| | Radiculopathy | 1 | 2007 | 27 | 0.070 |
Why?
| | Patient Discharge | 1 | 2013 | 772 | 0.070 |
Why?
| | Intervertebral Disc Displacement | 1 | 2007 | 36 | 0.070 |
Why?
| | Antipsychotic Agents | 1 | 2009 | 184 | 0.070 |
Why?
| | Bipolar Disorder | 1 | 2009 | 205 | 0.070 |
Why?
| | Critical Care | 1 | 2010 | 476 | 0.070 |
Why?
| | Consensus | 2 | 2022 | 537 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2538 | 0.070 |
Why?
| | Prostheses and Implants | 1 | 2007 | 137 | 0.070 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 350 | 0.070 |
Why?
| | Prevalence | 2 | 2013 | 2251 | 0.070 |
Why?
| | Biomechanical Phenomena | 2 | 2008 | 668 | 0.060 |
Why?
| | Hypotension, Orthostatic | 1 | 2004 | 7 | 0.060 |
Why?
| | Metatarsus | 1 | 2004 | 6 | 0.060 |
Why?
| | Lung | 2 | 2020 | 3559 | 0.060 |
Why?
| | Outpatients | 1 | 2007 | 326 | 0.060 |
Why?
| | Hallux Valgus | 1 | 2004 | 27 | 0.060 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2004 | 77 | 0.060 |
Why?
| | Patient Education as Topic | 2 | 2020 | 680 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3003 | 0.050 |
Why?
| | Spinal Neoplasms | 1 | 2003 | 28 | 0.050 |
Why?
| | Osteosarcoma | 1 | 2003 | 67 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2009 | 1518 | 0.050 |
Why?
| | Baclofen | 1 | 2022 | 10 | 0.050 |
Why?
| | Arnold-Chiari Malformation | 1 | 2002 | 30 | 0.050 |
Why?
| | Infusion Pumps, Implantable | 1 | 2022 | 20 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 152 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2011 | 3046 | 0.050 |
Why?
| | Middle Aged | 5 | 2016 | 26733 | 0.050 |
Why?
| | Infant | 2 | 2013 | 7961 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 2894 | 0.050 |
Why?
| | Depression | 1 | 2009 | 1134 | 0.050 |
Why?
| | Young Adult | 2 | 2013 | 10466 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 249 | 0.040 |
Why?
| | Time Factors | 3 | 2017 | 6114 | 0.040 |
Why?
| | Forced Expiratory Volume | 2 | 2012 | 475 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 1472 | 0.040 |
Why?
| | Disease Progression | 3 | 2019 | 2380 | 0.040 |
Why?
| | Menarche | 1 | 2019 | 49 | 0.040 |
Why?
| | Adult | 4 | 2020 | 30544 | 0.040 |
Why?
| | Pelvis | 1 | 2019 | 90 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2022 | 389 | 0.040 |
Why?
| | Pyomyositis | 1 | 2017 | 13 | 0.040 |
Why?
| | Bloodless Medical and Surgical Procedures | 1 | 2017 | 2 | 0.040 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2017 | 8 | 0.040 |
Why?
| | Braces | 1 | 2017 | 22 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 89 | 0.040 |
Why?
| | Ketorolac | 1 | 2017 | 16 | 0.040 |
Why?
| | Injections, Spinal | 1 | 2017 | 101 | 0.040 |
Why?
| | Central Venous Catheters | 1 | 2017 | 40 | 0.040 |
Why?
| | Observer Variation | 1 | 2018 | 295 | 0.040 |
Why?
| | Diphosphonates | 1 | 2017 | 51 | 0.040 |
Why?
| | Organ Size | 1 | 2018 | 434 | 0.030 |
Why?
| | Arthritis, Infectious | 1 | 2017 | 49 | 0.030 |
Why?
| | Operative Time | 1 | 2017 | 106 | 0.030 |
Why?
| | Abscess | 1 | 2017 | 72 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 153 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2017 | 62 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2017 | 124 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2017 | 159 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 144 | 0.030 |
Why?
| | Postoperative Period | 1 | 2017 | 289 | 0.030 |
Why?
| | Fever | 1 | 2017 | 280 | 0.030 |
Why?
| | Perioperative Care | 1 | 2017 | 127 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2017 | 105 | 0.030 |
Why?
| | Self-Assessment | 1 | 2016 | 60 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2012 | 1121 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 953 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 911 | 0.030 |
Why?
| | Comprehension | 1 | 2016 | 156 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2017 | 1660 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 573 | 0.030 |
Why?
| | Body Mass Index | 1 | 2019 | 1958 | 0.020 |
Why?
| | Drainage | 1 | 2012 | 151 | 0.020 |
Why?
| | Preoperative Period | 1 | 2011 | 103 | 0.020 |
Why?
| | Vital Capacity | 1 | 2011 | 255 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4408 | 0.020 |
Why?
| | Health Care Costs | 1 | 2013 | 381 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2011 | 522 | 0.020 |
Why?
| | Quetiapine Fumarate | 1 | 2009 | 22 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 944 | 0.020 |
Why?
| | Recovery of Function | 1 | 2011 | 574 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4099 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1125 | 0.020 |
Why?
| | Cadaver | 1 | 2008 | 299 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1692 | 0.020 |
Why?
| | Suicide, Attempted | 1 | 2009 | 317 | 0.020 |
Why?
| | Mass Screening | 1 | 2011 | 1004 | 0.010 |
Why?
| | Endpoint Determination | 1 | 2004 | 68 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2218 | 0.010 |
Why?
| | Lordosis | 1 | 2003 | 12 | 0.010 |
Why?
| | Stereotaxic Techniques | 1 | 2003 | 29 | 0.010 |
Why?
| | Survival | 1 | 2003 | 37 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2004 | 440 | 0.010 |
Why?
| | Morbidity | 1 | 2003 | 280 | 0.010 |
Why?
| | Rats | 1 | 2009 | 4958 | 0.010 |
Why?
| | Pilot Projects | 1 | 2004 | 1373 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 1538 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1355 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2285 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2004 | 6345 | 0.010 |
Why?
| | Animals | 1 | 2009 | 31698 | 0.000 |
Why?
| | Aged | 1 | 2004 | 19069 | 0.000 |
Why?
|
|
Erickson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|